dT-5' CPG Column
CPG column for incorporation of an (otherwise unmodified) reverse (5' to 3') dT nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of an (otherwise unmodified) reverse (5' to 3') dT nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG column for the incorporation of an (otherwise unmodified) reverse (5' to 3') dA nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of an (otherwise unmodified) reverse (5' to 3') dG nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of a 2'-O-methyl modified U nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of a 2'-O-methyl modified ribo-C nucleobase at the 3' end of an oligonucleotide.
CPG column for the incorporation of a 2'-O-methyl modified ribo-A nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of a 2'-O-methyl modified ribo-C nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of a 2'-O-methyl modified ribo-G nucleobase at the 3' end of an oligonucleotide.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |